WLG
TEVA icon

Williamson Legacy Group’s Teva Pharmaceuticals TEVA Stock Holding History

Williamson Legacy Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57,824
Closed -$1.27M – 131
2024
Q4 		$1.27M Buy
57,824
+979
+2% +$17.8K 0.85% 26
2024
Q3 		$1.02M Buy
56,845
+13,492
+31% +$236K 0.68% 36
2024
Q2 		$704K Buy
+43,353
New +$668K 0.52% 61

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Williamson Legacy Group's TEVA Position: Q1 2025 in Review

Williamson Legacy Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 57,824 shares — an estimated $1.27M sold.

Williamson Legacy Group first reported a position in TEVA in Q2 2024 and held it in 3 quarters. The position peaked at $1.27M in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Williamson Legacy Group reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Williamson Legacy Group sold 57,824 Teva Pharmaceuticals shares in Q1 2025, an estimated $1.27M.
  • Williamson Legacy Group first reported a position in Teva Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Williamson Legacy Group's Teva Pharmaceuticals position peaked at $1.27M in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Williamson Legacy Group's 13F filing for Q1 2025, filed 8 May 2025.